Previous studies have demonstrated an increase in FOSL2 expression during lung fibrosis and in systemic sclerosis models,[11,28] suggesting that upregulation of FOSL2 may be a common feature of many fibrotic disorders. The gene discussed is FOSL2; the disease is pulmonary fibrosis.